Intrinsic Value of S&P & Nasdaq Contact Us

Welltower Inc. WELL NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
65/100
4/7 Pass
SharesGrow Intrinsic Value
$60.49
-71.3%
Analyst Price Target
$225.40
+6.8%

Welltower Inc. (WELL) is a REIT - Healthcare Facilities company in the Real Estate sector, currently trading at $210.99. It has a SharesGrow Score of 65/100, indicating a above average investment profile with 4 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of WELL = $60.49 (-71.3% from the current price, the stock appears overvalued). Analyst consensus target is WELL = $225 (+6.8% upside).

Valuation: WELL trades at a trailing Price-to-Earnings (P/E) of 151.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 10.8.

Financials: revenue is $10.7B, +22.5%/yr average growth. Net income is $937M, growing at +106.4%/yr. Net profit margin is 8.8% (thin). Gross margin is 39.2% (-0.1 pp trend).

Balance sheet: total debt is $21.4B against $42.1B equity (Debt-to-Equity (D/E) ratio 0.51, moderate). Current ratio is 5.34 (strong liquidity). Debt-to-assets is 31.8%. Total assets: $67.3B.

Analyst outlook: 21 / 34 analysts rate WELL as buy (62%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 27/100 (Fail), Growth 100/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 72/100 (Pass), Future 61/100 (Pass), Income 45/100 (Partial).

$225.40
▲ 6.83% Upside
Average Price Target
Based on 34 Wall Street analysts offering 12-month price targets for Welltower Inc., the average price target is $225.40, with a high forecast of $246.00, and a low forecast of $196.00.
Highest Price Target
$246.00
Average Price Target
$225.40
Lowest Price Target
$196.00

WELL SharesGrow Score Overview

65/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 27/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 72/100
Gross margin is + market cap
FUTURE 61/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — WELL

VALUE Fail
27/100
WELL trades at a trailing Price-to-Earnings (P/E) of 151.4 (S&P 500 average ~25). Forward PEG 10.8 — overvalued. Analyst consensus target is $225, implying +6.6% from the current price $211. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
WELL: +22.5%/yr revenue is, +106.4%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
WELL: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet WELL: Debt-to-Equity (D/E) ratio 0.51 (moderate), Current ratio is 5.34 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Pass
72/100
WELL: Gross margin is 39.2% (-0.1 pp trend), $147B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 72/100. ≥ 70 = Pass.
View details →
FUTURE Pass
61/100
Analyst outlook: 21 / 34 analysts rate WELL as buy (62%). Analyst consensus target is $225 (+6.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
45/100
WELL: Net profit margin is 8.8%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range130.29-216.43
Volume1.68M
Avg Volume (30D)3.22M
Market Cap$147.22B
Beta (1Y)0.82
Dividend Yield$2.8900
Share Statistics
EPS (TTM)1.41
Shares Outstanding$665.64M
IPO Date1980-03-19
Employees685
CEOShankh S. Mitra
Financial Highlights & Ratios
Revenue (TTM)$10.67B
Gross Profit$4.18B
EBITDA$2.31B
Net Income$936.85M
Operating Income$355.17M
Total Cash$5.03B
Total Debt$21.38B
Net Debt$16.35B
Total Assets$67.3B
Price / Earnings (P/E)149.6
Price / Sales (P/S)13.8
Analyst Forecast
1Y Price Target$230.00
Target High$246.00
Target Low$196.00
Upside+9.0%
Rating ConsensusBuy
Analysts Covering34
Buy 62% Hold 38% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS95040Q1040

Price Chart

WELL
Welltower Inc.  ·  NYSE
Real Estate • REIT - Healthcare Facilities
130.29 52WK RANGE 216.43
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message